Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

NCT00627432 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: oxaliplatin

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle